Informace o publikaci

Naringenin as a dual-target modulator of RAGE-NF-κB signaling and Aβ fibrillization in Alzheimer's disease: integrated computational and experimental analyses

Logo poskytovatele
Autoři

BHOGAL Inderjeet FRYDRYCH Ivo MODI Ajay PANKAJ Vaishali KUMAR Akhil KHAIRNAR Amit Suresh DAS Viswanath ROY Sudeep

Rok publikování 2026
Druh Recenzovaný odborný článek
Časopis / Zdroj FRONTIERS IN PHARMACOLOGY
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1901236/full
Doi https://doi.org/10.3389/fphar.2026.1901236
Klíčová slova Alzheimer's disease; A beta aggregation; dual-target inhibitors; naringenin; neuroinflammation; RAGE signaling
Popis Introduction Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by the accumulation and aggregation of beta-amyloid (A beta) and chronic neuroinflammation mediated by the receptor for advanced glycation end products (RAGE). Current therapeutic candidates targeting RAGE signaling or A beta aggregation continue to face challenges, including off-target toxicity, poor blood-brain barrier (BBB) penetration, and limited multi-target efficacy.Methods Naringenin (NAR), a naturally occurring flavanone polyphenol prioritized through structure-based virtual screening and preliminary biological evaluation, was selected for further mechanistic investigation as a potential dual-target modulator of RAGE-associated inflammatory signaling and A beta 42 fibrillization.Results Molecular docking analyses showed that NAR interacts with the RAGE interface (PDB: 6XQ3) via pi-cation interactions with ARG_98 and LYS_110 (docking score: -5.072 kcal/mol). At the A beta fibril (PDB: 2MXU), NAR showed a superior docking score than ALZ-801 (valiltramiprosate), involving hydrogen bonding and pi-pi stacking with HIS_A14 (docking score: -8.098 kcal/mol). 100 ns molecular dynamics simulations supported the stability of these binding modes, with RMSD and RMSF values within acceptable ranges. MM-GBSA rescoring indicated competitive predicted binding free energies (Delta GBind: -30.260 kcal/mol at RAGE; -220.162 kcal/mol at the fibril, compared to ALZ- 801's -214.482 kcal/mol), influenced by electrostatic and hydrophobic interactions. Per-residue energy decomposition indicated PHE_20 (-9.10 kcal/ mol) as the dominant hotspot residue, alongside ARG_98 (-4.71 kcal/mol) and LYS_52 (-3.96 kcal/mol) as key RAGE anchors. In silico ADMET profiling suggested favorable predicted BBB accessibility (score: 0.001), Caco-2 permeability, Lipinski compliance, and a more favorable predicted cardiac safety profile (hERG: 0.145) relative to V6Y. Experimentally, NAR reduced A beta 42-induced NF-kappa B activation in RAGE-positive C6 cells, protected SH-SY5Y neurons from A beta 42 toxicity, and inhibited A beta 42 fibrillization in vitro, producing non-seeding aggregates consistent with impaired fibril formation, and attenuated rotenone-induced alpha-synuclein-associated cellular stress.Discussion Collectively, these findings support further investigation of NAR as a mechanistically plausible multi-target candidate for protein aggregation and RAGE-associated inflammatory signaling in neurodegenerative disease models.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info